Search Count: 22
 |
Influenza A Virus Polymerase Pa Subunit Endonuclease Domain Bound To Inhibitor Compound 19A
Organism: Influenza a virus
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2025-01-29 Classification: HYDROLASE/INHIBITOR Ligands: MN, A1A8U, MLI |
 |
Organism: Plasmodium vivax sal-1
Method: X-RAY DIFFRACTION Release Date: 2024-08-28 Classification: HYDROLASE Ligands: SKC, TEW, NAG, TRS |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.44 Å Release Date: 2024-03-06 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: I70, PO4 |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2024-03-06 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: X83 |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.44 Å Release Date: 2024-03-06 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: X8F |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2024-03-06 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: XKQ, EDO |
 |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-05-04 Classification: HYDROLASE Ligands: NAG, ACT, GOL |
 |
Crystal Structure Of Plasmepsin X From Plasmodium Falciparum In Complex With Wm382
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:2.76 Å Release Date: 2022-05-04 Classification: HYDROLASE Ligands: EDO, NAG, PG4, I0L |
 |
Crystal Structure Of Plasmepsin X From Plasmodium Vivax In Complex With Wm382
Organism: Plasmodium vivax
Method: X-RAY DIFFRACTION Resolution:2.22 Å Release Date: 2022-05-04 Classification: HYDROLASE Ligands: I0L, GOL |
 |
Crystal Structure Of Plasmepsin X From Plasmodium Vivax In Complex With Wm4
Organism: Plasmodium vivax
Method: X-RAY DIFFRACTION Resolution:3.35 Å Release Date: 2022-05-04 Classification: HYDROLASE Ligands: I0I, SO4 |
 |
Crystal Structure Of Hiv Protease Complexed With (S)-N-(3-Fluoro-2-(2-(1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKD |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6R)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKM |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6R)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKS |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,5S)-5-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKV |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6S)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKY |
 |
Crystal Structure Of Hiv Protease Complexed With N-(2-(2-((6R,9S)-2,2-Dioxido-2-Thia-1,7-Diazabicyclo[4.3.1]Decan-9-Yl)Ethyl)-3-Fluorophenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CN4, CL |
 |
Trka With (6~{R})-3-Methylsulfanyl-6-Phenyl-1-(1~{H}-Pyrazol-3-Yl)-6,7-Dihydro-5~{H}-Thieno[3,4-C]Pyridin-4-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.33 Å Release Date: 2017-08-09 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 69C, CL, ACT |
 |
Discovery Of Mli-2, An Orally Available And Selective Lrrk2 Inhibitor That Reduces Brain Kinase Activity
Organism: Rattus norvegicus
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2017-03-15 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 81Y, SO4 |
 |
Crystal Structure Of Hiv Protease Complexed With Methyl N-[(1S)-1-Benzhydryl-2-(3-Morpholin-4-Ium-2-Ylpropylamino)-2-Oxo-Ethyl]Carbamate
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2016-05-18 Classification: HYDROLASE/INHIBITOR Ligands: 6EH, CL |
 |
Crystal Structure Of Hiv Protease Complexed With Methyl N-[(1S)-1-[[2-[(3S)-3-[(4-Aminophenyl)Methylamino]-4-Hydroxy-Butyl]Phenyl]Carbamoyl]-2,2-Diphenyl-Ethyl]Carbamate
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2016-05-18 Classification: HYDROLASE/INHIBITOR Ligands: CL, 6EG |